Cargando…
Effect of simvastatin on monocyte chemoattractant protein-1 expression in endometriosis patients: a randomized controlled trial
BACKGROUND: Simvastatin is a promising new drug for the treatment of endometriosis. It is a cholesterol-lowering drug that acts by inhibiting HMG-CoA reductase, resulting in a decrease in mevalonate, a precursor of cholesterol and monocyte chemoattractant protein-1 (MCP-1). This study investigated t...
Autores principales: | Waiyaput, Wanwisa, Pumipichet, Somphoch, Weerakiet, Sawaek, Rattanasiri, Sasivimol, Sophonsritsuk, Areepan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615793/ https://www.ncbi.nlm.nih.gov/pubmed/28950844 http://dx.doi.org/10.1186/s12905-017-0446-3 |
Ejemplares similares
-
The Effect of Combined Oral Contraceptive Pills on Beclin-1 and LC3B Transcript Levels in Ovarian Endometrioma
por: Waiyaput, Wanwisa, et al.
Publicado: (2021) -
Effects of Ethinyl Estradiol in Combined Oral Contraceptives on Cell Proliferation and Apoptosis in Ectopic Endometrial Tissue: A Randomized Controlled Study
por: Sophonsritsuk, Areepan, et al.
Publicado: (2021) -
The Effects of Dienogest on Macrophage and Natural Killer
Cells in Adenomyosis: A Randomized Controlled Study
por: Prathoomthong, Saowapak, et al.
Publicado: (2018) -
A Comparison of Shear Wave Elastography between Normal
Myometrium, Uterine Fibroids, and Adenomyosis:
A Cross-Sectional Study
por: Pongpunprut, Sutee, et al.
Publicado: (2022) -
Vaginal microbiome of women with adenomyosis: A case-control study
por: Kunaseth, Jitsupa, et al.
Publicado: (2022)